Dutch health institute warns of overdose risk from Trump-shaped ecstasy pills

A national health institute has issued a warning that certain drugs exhibit a delayed pharmacological effect, a characteristic that “increases the risk of overdose,” according to the agency’s latest advisory. The statement highlights concerns that the lag between ingestion and perceived impact may lead users to consume additional doses before the initial dose takes full effect, inadvertently elevating the likelihood of toxic exposure.

The institute advises healthcare providers, harm‑reduction services and the public to be aware of this delayed onset and to educate potential users about the dangers of re‑dosing. It recommends that individuals refrain from taking extra amounts within a short timeframe and seek immediate medical assistance if they experience unexpected symptoms. The advisory underscores the importance of timely information to mitigate overdose incidents linked to the delayed action of these substances.